$LGND Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LIGAND PHARMACEUTICALS INC. Get notifications about new insider transactions in LIGAND PHARMACEUTICALS INC for free.
Page: < prev 1 ... 5 6 7 8 9 10 11 12 13 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 15 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.99 | 3,448 | 41,342 | 351,182 | 347.7 K to 351.2 K (+0.99 %) |
Aug 15 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.99 | 800 | 9,592 | 84,733 | 83.9 K to 84.7 K (+0.95 %) |
Aug 15 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.99 | 2,200 | 26,378 | 207,171 | 205 K to 207.2 K (+1.07 %) |
Aug 15 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.99 | 7,300 | 87,527 | 687,780 | 680.5 K to 687.8 K (+1.07 %) |
Aug 15 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 11.19 | 926 | 10,363 | 1,636,862 | 1.6 M to 1.6 M (+0.06 %) |
Aug 15 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 11.19 | 217 | 2,429 | 357,380 | 357.2 K to 357.4 K (+0.06 %) |
Aug 15 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 11.19 | 251 | 2,809 | 579,887 | 579.6 K to 579.9 K (+0.04 %) |
Aug 12 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.45 | 1,900 | 21,755 | 347,734 | 345.8 K to 347.7 K (+0.55 %) |
Aug 12 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.45 | 1,500 | 17,175 | 83,933 | 82.4 K to 83.9 K (+1.82 %) |
Aug 12 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.45 | 3,900 | 44,655 | 204,971 | 201.1 K to 205 K (+1.94 %) |
Aug 12 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.45 | 12,700 | 145,415 | 680,480 | 667.8 K to 680.5 K (+1.90 %) |
Aug 12 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 10.80 | 5,600 | 60,480 | 25,700 | 20.1 K to 25.7 K (+27.86 %) |
Aug 12 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 10.80 | 6,900 | 74,520 | 41,483 | 34.6 K to 41.5 K (+19.95 %) |
Aug 12 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 10.80 | 7,400 | 79,920 | 82,433 | 75 K to 82.4 K (+9.86 %) |
Aug 12 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 10.80 | 24,500 | 264,600 | 201,071 | 176.6 K to 201.1 K (+13.88 %) |
Aug 12 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 10.80 | 80,600 | 870,480 | 667,780 | 587.2 K to 667.8 K (+13.73 %) |
Aug 11 2011 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | P | 10.90 | 15,000 | 163,500 | 29,201 | 14.2 K to 29.2 K (+105.63 %) |
Aug 11 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 10.75 | 3,456 | 37,138 | 25,705 | 22.2 K to 25.7 K (+15.53 %) |
Aug 11 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 10.74 | 384 | 4,123 | 22,249 | 21.9 K to 22.2 K (+1.76 %) |
Aug 11 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 10.75 | 100 | 1,075 | 21,865 | 21.8 K to 21.9 K (+0.46 %) |
Aug 11 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 10.74 | 100 | 1,074 | 21,765 | 21.7 K to 21.8 K (+0.46 %) |
Aug 11 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 10.73 | 700 | 7,509 | 21,665 | 21 K to 21.7 K (+3.34 %) |
Aug 11 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 10.72 | 260 | 2,787 | 20,965 | 20.7 K to 21 K (+1.26 %) |
Aug 11 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 10.57 | 2,000 | 21,140 | 283,336 | 281.3 K to 283.3 K (+0.71 %) |
Aug 10 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 10.91 | 148,200 | 1,617,262 | 1,635,936 | 1.5 M to 1.6 M (+9.96 %) |
Aug 10 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 10.91 | 32,400 | 353,571 | 357,163 | 324.8 K to 357.2 K (+9.98 %) |
Aug 10 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 10.91 | 52,400 | 571,825 | 579,636 | 527.2 K to 579.6 K (+9.94 %) |
Aug 10 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 10.86 | 133,000 | 1,444,912 | 1,487,736 | 1.4 M to 1.5 M (+9.82 %) |
Aug 10 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 10.86 | 13,200 | 143,405 | 324,763 | 311.6 K to 324.8 K (+4.24 %) |
Aug 10 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 10.86 | 44,700 | 485,621 | 527,236 | 482.5 K to 527.2 K (+9.26 %) |
Aug 10 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 11.20 | 156,100 | 1,748,944 | 1,354,736 | 1.2 M to 1.4 M (+13.02 %) |
Aug 10 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 11.20 | 19,700 | 220,719 | 482,536 | 462.8 K to 482.5 K (+4.26 %) |
Jul 26 2011 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | President & CEO | Buy | J | 7.64 | 277 | 2,116 | 89,065 | 88.8 K to 89.1 K (+0.31 %) |
Jul 26 2011 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | President & CEO | Buy | J | 7.14 | 294 | 2,099 | 73,788 | 73.5 K to 73.8 K (+0.40 %) |
Jun 06 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Option Exercise | A | 10.12 | 7,335 | 74,230 | 7,335 | |
Jun 06 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | J | 0.00 | 7,372 | 0 | 50,705 | 43.3 K to 50.7 K (+17.01 %) |
Jun 06 2011 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Option Exercise | A | 10.12 | 7,335 | 74,230 | 7,335 | |
Jun 06 2011 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Buy | J | 0.00 | 7,372 | 0 | 10,704 | 3.3 K to 10.7 K (+221.25 %) |
Jun 06 2011 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Option Exercise | A | 17.88 | 2,500 | 44,700 | 2,500 | |
Jun 06 2011 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Option Exercise | D | 2.98 | 15,000 | 44,700 | 0 | |
Jun 06 2011 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Option Exercise | A | 8.58 | 2,500 | 21,450 | 2,500 | |
Jun 06 2011 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Option Exercise | D | 1.43 | 15,000 | 21,450 | 0 | |
Jun 06 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Option Exercise | A | 53.34 | 3,333 | 177,782 | 3,333 | |
Jun 06 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Option Exercise | D | 8.89 | 20,000 | 177,800 | 0 | |
Jun 06 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Option Exercise | A | 17.88 | 2,500 | 44,700 | 2,500 | |
Jun 06 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Option Exercise | D | 2.98 | 15,000 | 44,700 | 0 | |
Jun 06 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Option Exercise | A | 8.58 | 2,500 | 21,450 | 2,500 | |
Jun 06 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Option Exercise | D | 1.43 | 15,000 | 21,450 | 0 | |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 10.12 | 7,335 | 74,230 | 7,335 | |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 4,447 | 0 | 14,201 | 9.8 K to 14.2 K (+45.59 %) |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 2,925 | 0 | 9,754 | 6.8 K to 9.8 K (+42.83 %) |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 10.12 | 7,335 | 74,230 | 7,335 | |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 4,447 | 0 | 26,098 | 21.7 K to 26.1 K (+20.54 %) |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 2,925 | 0 | 21,651 | 18.7 K to 21.7 K (+15.62 %) |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Option Exercise | A | 10.12 | 7,335 | 74,230 | 7,335 | |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Grant | A | 0.00 | 2,223 | 0 | 16,814 | 14.6 K to 16.8 K (+15.24 %) |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Grant | A | 0.00 | 2,925 | 0 | 14,591 | 11.7 K to 14.6 K (+25.07 %) |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 10.12 | 7,335 | 74,230 | 7,335 | |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 4,447 | 0 | 20,705 | 16.3 K to 20.7 K (+27.35 %) |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 2,925 | 0 | 16,258 | 13.3 K to 16.3 K (+21.94 %) |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 10.12 | 7,335 | 74,230 | 7,335 | |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 4,447 | 0 | 21,801 | 17.4 K to 21.8 K (+25.63 %) |
Jun 03 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 2,925 | 0 | 17,354 | 14.4 K to 17.4 K (+20.27 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.75 | 500 | 4,875 | 3,025 | 2.5 K to 3 K (+19.80 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.91 | 500 | 4,955 | 2,525 | 2 K to 2.5 K (+24.69 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.87 | 500 | 4,935 | 270,111 | 269.6 K to 270.1 K (+0.19 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.86 | 500 | 4,930 | 269,611 | 269.1 K to 269.6 K (+0.19 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.85 | 500 | 4,925 | 269,111 | 268.6 K to 269.1 K (+0.19 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.84 | 500 | 4,920 | 268,611 | 268.1 K to 268.6 K (+0.19 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.83 | 500 | 4,915 | 268,111 | 267.6 K to 268.1 K (+0.19 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.80 | 500 | 4,900 | 267,611 | 267.1 K to 267.6 K (+0.19 %) |
May 13 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 10.96 | 1,725 | 18,906 | 281,336 | 279.6 K to 281.3 K (+0.62 %) |
Apr 20 2011 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | A | 9.97 | 25,000 | 249,250 | 116,547 | |
Apr 20 2011 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | A | 9.97 | 25,000 | 249,250 | 91,547 | |
Apr 20 2011 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | A | 9.97 | 15,000 | 149,550 | 66,547 | |
Apr 20 2011 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | A | 9.97 | 51,547 | 513,924 | 51,547 | |
Apr 20 2011 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | A | 9.97 | 48,453 | 483,076 | 48,453 | |
Apr 20 2011 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Mar 15 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.77 | 500 | 4,885 | 271,111 | 270.6 K to 271.1 K (+0.18 %) |
Mar 15 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.73 | 500 | 4,865 | 270,611 | 270.1 K to 270.6 K (+0.19 %) |
Mar 15 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.72 | 500 | 4,860 | 270,111 | 269.6 K to 270.1 K (+0.19 %) |
Mar 15 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.70 | 500 | 4,850 | 269,611 | 269.1 K to 269.6 K (+0.19 %) |
Mar 15 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.66 | 500 | 4,830 | 269,111 | 268.6 K to 269.1 K (+0.19 %) |
Mar 15 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.63 | 500 | 4,815 | 268,611 | 268.1 K to 268.6 K (+0.19 %) |
Mar 15 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.59 | 500 | 4,795 | 268,111 | 267.6 K to 268.1 K (+0.19 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.48 | 500 | 4,740 | 276,611 | 276.1 K to 276.6 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.46 | 500 | 4,730 | 276,111 | 275.6 K to 276.1 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.42 | 500 | 4,710 | 275,611 | 275.1 K to 275.6 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.36 | 500 | 4,680 | 275,111 | 274.6 K to 275.1 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.31 | 500 | 4,655 | 274,611 | 274.1 K to 274.6 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.27 | 500 | 4,635 | 274,111 | 273.6 K to 274.1 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.26 | 500 | 4,630 | 273,611 | 273.1 K to 273.6 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.25 | 500 | 4,625 | 273,111 | 272.6 K to 273.1 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.53 | 500 | 4,765 | 272,611 | 272.1 K to 272.6 K (+0.18 %) |
Mar 16 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.47 | 1,000 | 9,470 | 272,111 | 271.1 K to 272.1 K (+0.37 %) |
Mar 14 2011 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Buy | P | 9.88 | 600 | 5,928 | 11,666 | 11.1 K to 11.7 K (+5.42 %) |
Mar 14 2011 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Buy | P | 9.88 | 700 | 6,915 | 11,066 | 10.4 K to 11.1 K (+6.75 %) |
Mar 14 2011 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Buy | P | 9.88 | 3,700 | 36,538 | 10,366 | 6.7 K to 10.4 K (+55.51 %) |
Mar 14 2011 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Buy | P | 9.73 | 3,899 | 37,937 | 6,666 | 2.8 K to 6.7 K (+140.91 %) |
Mar 14 2011 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Buy | P | 9.73 | 1,101 | 10,712 | 2,767 | 1.7 K to 2.8 K (+66.09 %) |
Mar 14 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 10.01 | 500 | 5,005 | 3,025 | 2.5 K to 3 K (+19.80 %) |
Mar 14 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 10.08 | 500 | 5,040 | 2,525 | 2 K to 2.5 K (+24.69 %) |
Mar 14 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 10.16 | 500 | 5,080 | 267,611 | 267.1 K to 267.6 K (+0.19 %) |
Mar 07 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.02 | 13,400 | 147,668 | 20,100 | 6.7 K to 20.1 K (+200.00 %) |
Mar 07 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.02 | 23,000 | 253,460 | 34,583 | 11.6 K to 34.6 K (+198.57 %) |
Mar 07 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.02 | 1,000 | 11,020 | 1,666 | 666 to 1.7 K (+150.15 %) |
Mar 01 2011 | LGND | LIGAND PHARMACEUTI ... | Kazmi Syed | VP, Bus. Dev. & Str ... | Sell | S | 10.68 | 866 | 9,249 | 14,230 | 15.1 K to 14.2 K (-5.74 %) |
Mar 01 2011 | LGND | LIGAND PHARMACEUTI ... | Kazmi Syed | VP, Bus. Dev. & Str ... | Sell | S | 10.69 | 100 | 1,069 | 15,096 | 15.2 K to 15.1 K (-0.66 %) |
Mar 01 2011 | LGND | LIGAND PHARMACEUTI ... | Kazmi Syed | VP, Bus. Dev. & Str ... | Sell | S | 10.71 | 100 | 1,071 | 15,196 | 15.3 K to 15.2 K (-0.65 %) |
Mar 01 2011 | LGND | LIGAND PHARMACEUTI ... | Kazmi Syed | VP, Bus. Dev. & Str ... | Sell | S | 10.70 | 100 | 1,070 | 15,296 | 15.4 K to 15.3 K (-0.65 %) |
Feb 28 2011 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 9.99 | 1,789 | 17,872 | 18,726 | 16.9 K to 18.7 K (+10.56 %) |
Feb 28 2011 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 9.96 | 1,000 | 9,959 | 16,937 | 15.9 K to 16.9 K (+6.27 %) |
Feb 28 2011 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 10.00 | 2,000 | 20,000 | 15,937 | 13.9 K to 15.9 K (+14.35 %) |
Feb 28 2011 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 9.94 | 211 | 2,097 | 13,937 | 13.7 K to 13.9 K (+1.54 %) |
Feb 28 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 10.84 | 9,252 | 100,292 | 42,500 | 33.2 K to 42.5 K (+27.83 %) |
Feb 28 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 10.02 | 14,432 | 144,609 | 33,248 | 18.8 K to 33.2 K (+76.70 %) |
Feb 28 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 9.99 | 16,316 | 162,997 | 18,816 | 2.5 K to 18.8 K (+652.64 %) |
Feb 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 9.99 | 6,700 | 66,933 | 6,700 | 0 to 6.7 K |
Feb 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Sell | S | 9.95 | 31,331 | 311,743 | 0 | 31.3 K to 0 (-100.00 %) |
Feb 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Sell | S | 9.95 | 10,382 | 103,301 | 0 | 10.4 K to 0 (-100.00 %) |
Feb 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Sell | S | 9.95 | 47,087 | 468,516 | 345,834 | 392.9 K to 345.8 K (-11.98 %) |
Feb 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 9.95 | 21,400 | 212,930 | 75,033 | 53.6 K to 75 K (+39.90 %) |
Feb 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 9.95 | 2,200 | 21,890 | 176,571 | 174.4 K to 176.6 K (+1.26 %) |
Feb 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 9.95 | 65,200 | 648,740 | 587,180 | 522 K to 587.2 K (+12.49 %) |
Feb 23 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 9.94 | 5,000 | 49,700 | 267,111 | 262.1 K to 267.1 K (+1.91 %) |
Feb 22 2011 | LGND | LIGAND PHARMACEUTI ... | Kazmi Syed | VP, Bus. Dev. & Str ... | Option Exercise | A | 10.05 | 2,487 | 24,994 | 2,487 | |
Feb 22 2011 | LGND | LIGAND PHARMACEUTI ... | Kazmi Syed | VP, Bus. Dev. & Str ... | Option Exercise | A | 10.05 | 30,000 | 301,500 | 30,000 | |
Feb 22 2011 | LGND | LIGAND PHARMACEUTI ... | Kazmi Syed | VP, Bus. Dev. & Str ... | Option Exercise | A | 10.05 | 7,513 | 75,506 | 7,513 | |
Feb 22 2011 | LGND | LIGAND PHARMACEUTI ... | Kazmi Syed | VP, Bus. Dev. & Str ... | Grant | A | 0.00 | 3,000 | 0 | 15,396 | 12.4 K to 15.4 K (+24.20 %) |
Feb 18 2011 | LGND | LIGAND PHARMACEUTI ... | Sharp John P | VP Finance and CFO | Option Exercise | A | 10.05 | 6,086 | 61,164 | 6,086 | |
Feb 18 2011 | LGND | LIGAND PHARMACEUTI ... | Sharp John P | VP Finance and CFO | Option Exercise | A | 10.05 | 23,914 | 240,336 | 23,914 | |
Feb 18 2011 | LGND | LIGAND PHARMACEUTI ... | Sharp John P | VP Finance and CFO | Grant | A | 0.00 | 3,000 | 0 | 16,666 | 13.7 K to 16.7 K (+21.95 %) |
Feb 18 2011 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | President & CEO | Option Exercise | A | 10.05 | 94,657 | 951,303 | 94,657 | |
Feb 18 2011 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | President & CEO | Option Exercise | A | 10.05 | 20,343 | 204,447 | 20,343 | |
Feb 18 2011 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | President & CEO | Grant | A | 0.00 | 15,000 | 0 | 88,494 | 73.5 K to 88.5 K (+20.41 %) |
Feb 18 2011 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 10.05 | 4,779 | 48,029 | 4,779 | |
Feb 18 2011 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 10.05 | 10,221 | 102,721 | 10,221 | |
Feb 18 2011 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Grant | A | 0.00 | 3,000 | 0 | 14,696 | 11.7 K to 14.7 K (+25.65 %) |
Feb 18 2011 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 9.75 | 5,000 | 48,751 | 11,696 | 16.7 K to 11.7 K (-29.95 %) |
Feb 17 2011 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Buy | P | 9.90 | 1,000 | 9,900 | 13,726 | 12.7 K to 13.7 K (+7.86 %) |
Feb 17 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 9.25 | 3,700 | 34,225 | 13,333 | 9.6 K to 13.3 K (+38.41 %) |
Feb 17 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 9.25 | 411 | 3,801 | 9,633 | 9.2 K to 9.6 K (+4.46 %) |
Feb 17 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 9.19 | 5,189 | 47,687 | 9,222 | 4 K to 9.2 K (+128.66 %) |
Feb 17 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 9.25 | 500 | 4,625 | 4,033 | 3.5 K to 4 K (+14.15 %) |
Feb 17 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 9.18 | 200 | 1,836 | 3,533 | 3.3 K to 3.5 K (+6.00 %) |
Feb 10 2011 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Option Exercise | A | 8.97 | 5,000 | 44,850 | 5,000 | |
Feb 10 2011 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Grant | A | 0.00 | 1,666 | 0 | 1,666 | 0 to 1.7 K |
Nov 12 2010 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Buy | P | 1.60 | 10,000 | 15,954 | 76,357 | 66.4 K to 76.4 K (+15.07 %) |
Oct 08 2010 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 1.60 | 30,000 | 48,000 | 30,000 | |
Oct 08 2010 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |